Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Taken together, these data indicated that silibinin inhibits LoVo cell invasion with the reduction of MMP-2 presentation by attenuating AP-1 binding activity, suggesting a novel antimetastatic application for silibinin in colon cancer chemoprevention.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP674719.RAUzpBYZIqsI5fwV_sjX6AAlvzQkkUmQXPRytYp7a4LCw130_assertion description "[Taken together, these data indicated that silibinin inhibits LoVo cell invasion with the reduction of MMP-2 presentation by attenuating AP-1 binding activity, suggesting a novel antimetastatic application for silibinin in colon cancer chemoprevention.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP674719.RAUzpBYZIqsI5fwV_sjX6AAlvzQkkUmQXPRytYp7a4LCw130_provenance.
• assertion description "[Taken together, these data indicated that silibinin inhibits LoVo cell invasion with the reduction of MMP-2 presentation by attenuating AP-1 binding activity, suggesting a novel antimetastatic application for silibinin in colon cancer chemoprevention.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Taken together, these data indicated that silibinin inhibits LoVo cell invasion with the reduction of MMP-2 presentation by attenuating AP-1 binding activity, suggesting a novel antimetastatic application for silibinin in colon cancer chemoprevention.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Taken together, these data indicated that silibinin inhibits LoVo cell invasion with the reduction of MMP-2 presentation by attenuating AP-1 binding activity, suggesting a novel antimetastatic application for silibinin in colon cancer chemoprevention.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Taken together, these data indicated that silibinin inhibits LoVo cell invasion with the reduction of MMP-2 presentation by attenuating AP-1 binding activity, suggesting a novel antimetastatic application for silibinin in colon cancer chemoprevention.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP583266.RA_e6zOg0q_KtIcY2f47ZTK7MOG3B4FwfO6G2L2PRIsCY130_assertion description "[Taken together, these data indicated that silibinin inhibits LoVo cell invasion with the reduction of MMP-2 presentation by attenuating AP-1 binding activity, suggesting a novel antimetastatic application for silibinin in colon cancer chemoprevention.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP583266.RA_e6zOg0q_KtIcY2f47ZTK7MOG3B4FwfO6G2L2PRIsCY130_provenance.
• NP410604.RAXMhYBcV64xkNl89Zfgf8_eBZINYWuOZW_ndl5UPlKw8130_assertion description "[Taken together, these data indicated that silibinin inhibits LoVo cell invasion with the reduction of MMP-2 presentation by attenuating AP-1 binding activity, suggesting a novel antimetastatic application for silibinin in colon cancer chemoprevention.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP410604.RAXMhYBcV64xkNl89Zfgf8_eBZINYWuOZW_ndl5UPlKw8130_provenance.
• NP520219.RAeOTJzIf1AZPKrPo15O8rwTHI9tBZxwoJgLw93BDZ7Qs130_assertion description "[Taken together, these data indicated that silibinin inhibits LoVo cell invasion with the reduction of MMP-2 presentation by attenuating AP-1 binding activity, suggesting a novel antimetastatic application for silibinin in colon cancer chemoprevention.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP520219.RAeOTJzIf1AZPKrPo15O8rwTHI9tBZxwoJgLw93BDZ7Qs130_provenance.
• assertion description "[Taken together, these data indicated that silibinin inhibits LoVo cell invasion with the reduction of MMP-2 presentation by attenuating AP-1 binding activity, suggesting a novel antimetastatic application for silibinin in colon cancer chemoprevention.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Taken together, these data indicated that silibinin inhibits LoVo cell invasion with the reduction of MMP-2 presentation by attenuating AP-1 binding activity, suggesting a novel antimetastatic application for silibinin in colon cancer chemoprevention.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Taken together, these data indicated that silibinin inhibits LoVo cell invasion with the reduction of MMP-2 presentation by attenuating AP-1 binding activity, suggesting a novel antimetastatic application for silibinin in colon cancer chemoprevention.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Taken together, these data indicated that silibinin inhibits LoVo cell invasion with the reduction of MMP-2 presentation by attenuating AP-1 binding activity, suggesting a novel antimetastatic application for silibinin in colon cancer chemoprevention.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Taken together, these data indicated that silibinin inhibits LoVo cell invasion with the reduction of MMP-2 presentation by attenuating AP-1 binding activity, suggesting a novel antimetastatic application for silibinin in colon cancer chemoprevention.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Taken together, these data indicated that silibinin inhibits LoVo cell invasion with the reduction of MMP-2 presentation by attenuating AP-1 binding activity, suggesting a novel antimetastatic application for silibinin in colon cancer chemoprevention.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP1033397.RAVF4dgBwWsb67DKmCh43OMeTmphpKfXz7YHHI0aMMJAU130_assertion description "[Taken together, these data indicated that silibinin inhibits LoVo cell invasion with the reduction of MMP-2 presentation by attenuating AP-1 binding activity, suggesting a novel antimetastatic application for silibinin in colon cancer chemoprevention.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1033397.RAVF4dgBwWsb67DKmCh43OMeTmphpKfXz7YHHI0aMMJAU130_provenance.
• NP1033398.RAV-iNb3EF6kkeRffIq9cbvs1S0_8sU4AE62PNJzv95yY130_assertion description "[Taken together, these data indicated that silibinin inhibits LoVo cell invasion with the reduction of MMP-2 presentation by attenuating AP-1 binding activity, suggesting a novel antimetastatic application for silibinin in colon cancer chemoprevention.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1033398.RAV-iNb3EF6kkeRffIq9cbvs1S0_8sU4AE62PNJzv95yY130_provenance.
• NP1033400.RAcA6I2-c-u3nlltfAIq80BdHigYauK193rQ_bB3QeOfY130_assertion description "[Taken together, these data indicated that silibinin inhibits LoVo cell invasion with the reduction of MMP-2 presentation by attenuating AP-1 binding activity, suggesting a novel antimetastatic application for silibinin in colon cancer chemoprevention.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1033400.RAcA6I2-c-u3nlltfAIq80BdHigYauK193rQ_bB3QeOfY130_provenance.
• NP1033402.RAeSDvb3czFCS1yPOs1M2o9-LkRU4c3BwpbVNbdFS_abo130_assertion description "[Taken together, these data indicated that silibinin inhibits LoVo cell invasion with the reduction of MMP-2 presentation by attenuating AP-1 binding activity, suggesting a novel antimetastatic application for silibinin in colon cancer chemoprevention.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1033402.RAeSDvb3czFCS1yPOs1M2o9-LkRU4c3BwpbVNbdFS_abo130_provenance.
• NP1033406.RAVVMW0jmHDechqb0pBxIHdCkBq8DjIral8PL5fz7o_5Q130_assertion description "[Taken together, these data indicated that silibinin inhibits LoVo cell invasion with the reduction of MMP-2 presentation by attenuating AP-1 binding activity, suggesting a novel antimetastatic application for silibinin in colon cancer chemoprevention.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1033406.RAVVMW0jmHDechqb0pBxIHdCkBq8DjIral8PL5fz7o_5Q130_provenance.
• NP520589.RAjktCq9A6-39XzWN4pKebsjpj_udNXkJid8oXJQ4_AI4130_assertion description "[Taken together, these data indicated that silibinin inhibits LoVo cell invasion with the reduction of MMP-2 presentation by attenuating AP-1 binding activity, suggesting a novel antimetastatic application for silibinin in colon cancer chemoprevention.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP520589.RAjktCq9A6-39XzWN4pKebsjpj_udNXkJid8oXJQ4_AI4130_provenance.
• NP520731.RABOH0ZhnBrV8oo_uvaRAO06wC0IWzGk2rUnKtRlWBa_Q130_assertion description "[Taken together, these data indicated that silibinin inhibits LoVo cell invasion with the reduction of MMP-2 presentation by attenuating AP-1 binding activity, suggesting a novel antimetastatic application for silibinin in colon cancer chemoprevention.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP520731.RABOH0ZhnBrV8oo_uvaRAO06wC0IWzGk2rUnKtRlWBa_Q130_provenance.
• NP410984.RAho8CNa6_G_NvJ6gS4vy8WAd9nQej0jKSCRAUdb9lyV4130_assertion description "[Taken together, these data indicated that silibinin inhibits LoVo cell invasion with the reduction of MMP-2 presentation by attenuating AP-1 binding activity, suggesting a novel antimetastatic application for silibinin in colon cancer chemoprevention.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP410984.RAho8CNa6_G_NvJ6gS4vy8WAd9nQej0jKSCRAUdb9lyV4130_provenance.
• NP1033399.RAA9BKmEnKlsj8Xw4g3gnlp_JsekB9QD8H7L0AD3p7--E130_assertion description "[Taken together, these data indicated that silibinin inhibits LoVo cell invasion with the reduction of MMP-2 presentation by attenuating AP-1 binding activity, suggesting a novel antimetastatic application for silibinin in colon cancer chemoprevention.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1033399.RAA9BKmEnKlsj8Xw4g3gnlp_JsekB9QD8H7L0AD3p7--E130_provenance.
• NP1033401.RAqUnZfVgJkL-BmKU0V1ZykdPlNy7tSecotsW2xOo0zX8130_assertion description "[Taken together, these data indicated that silibinin inhibits LoVo cell invasion with the reduction of MMP-2 presentation by attenuating AP-1 binding activity, suggesting a novel antimetastatic application for silibinin in colon cancer chemoprevention.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1033401.RAqUnZfVgJkL-BmKU0V1ZykdPlNy7tSecotsW2xOo0zX8130_provenance.
• NP1033405.RAnwdtCh0U41r2D5RIHiI2q8f5fIa4Ei2V8BxGyD8kb1s130_assertion description "[Taken together, these data indicated that silibinin inhibits LoVo cell invasion with the reduction of MMP-2 presentation by attenuating AP-1 binding activity, suggesting a novel antimetastatic application for silibinin in colon cancer chemoprevention.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1033405.RAnwdtCh0U41r2D5RIHiI2q8f5fIa4Ei2V8BxGyD8kb1s130_provenance.
• NP410851.RAwVwQnvICsjoTFfNJ0EaAdejNV3oM-Q23jd4CXIj8Fr0130_assertion description "[Taken together, these data indicated that silibinin inhibits LoVo cell invasion with the reduction of MMP-2 presentation by attenuating AP-1 binding activity, suggesting a novel antimetastatic application for silibinin in colon cancer chemoprevention.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP410851.RAwVwQnvICsjoTFfNJ0EaAdejNV3oM-Q23jd4CXIj8Fr0130_provenance.
• NP411134.RA2J199lcqcTcpku_KqH3imwEs4b243WOTE3Kgjh-TtyM130_assertion description "[Taken together, these data indicated that silibinin inhibits LoVo cell invasion with the reduction of MMP-2 presentation by attenuating AP-1 binding activity, suggesting a novel antimetastatic application for silibinin in colon cancer chemoprevention.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP411134.RA2J199lcqcTcpku_KqH3imwEs4b243WOTE3Kgjh-TtyM130_provenance.
• NP520490.RAMHbiVC1lC9oq0QcNUckfa_Dho6URDhv-fcbl2C2V5ZE130_assertion description "[Taken together, these data indicated that silibinin inhibits LoVo cell invasion with the reduction of MMP-2 presentation by attenuating AP-1 binding activity, suggesting a novel antimetastatic application for silibinin in colon cancer chemoprevention.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP520490.RAMHbiVC1lC9oq0QcNUckfa_Dho6URDhv-fcbl2C2V5ZE130_provenance.
• NP520008.RA9zpObn2PhJtsASh3Drb6_l_a2pTw6IenDGt4jfBZiOg130_assertion description "[Taken together, these data indicated that silibinin inhibits LoVo cell invasion with the reduction of MMP-2 presentation by attenuating AP-1 binding activity, suggesting a novel antimetastatic application for silibinin in colon cancer chemoprevention.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP520008.RA9zpObn2PhJtsASh3Drb6_l_a2pTw6IenDGt4jfBZiOg130_provenance.
• NP520340.RAxJi3nlZEF6AH3sxtbWxw5-MT1DJ21_P43KGRNDVB7ms130_assertion description "[Taken together, these data indicated that silibinin inhibits LoVo cell invasion with the reduction of MMP-2 presentation by attenuating AP-1 binding activity, suggesting a novel antimetastatic application for silibinin in colon cancer chemoprevention.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP520340.RAxJi3nlZEF6AH3sxtbWxw5-MT1DJ21_P43KGRNDVB7ms130_provenance.
• NP1033403.RAKbFEhNFAiQ0gD4DTSDe_tCUzQN_XA6T1FqjmxGq6XGk130_assertion description "[Taken together, these data indicated that silibinin inhibits LoVo cell invasion with the reduction of MMP-2 presentation by attenuating AP-1 binding activity, suggesting a novel antimetastatic application for silibinin in colon cancer chemoprevention.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1033403.RAKbFEhNFAiQ0gD4DTSDe_tCUzQN_XA6T1FqjmxGq6XGk130_provenance.
• NP1033404.RA_uMfq2OXVgdNLjqCqX4uGm4AnIi1wTqjOpPNPb6cxrs130_assertion description "[Taken together, these data indicated that silibinin inhibits LoVo cell invasion with the reduction of MMP-2 presentation by attenuating AP-1 binding activity, suggesting a novel antimetastatic application for silibinin in colon cancer chemoprevention.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1033404.RA_uMfq2OXVgdNLjqCqX4uGm4AnIi1wTqjOpPNPb6cxrs130_provenance.